Findings on Vaccines Detailed by Investigators at Jilin University (Incorporation of a Tgf-beta 2-inhibiting Oligodeoxynucleotide Molecular Adjuvant Into a Tumor Cell Lysate Vaccine To Enhance Antiglioma Immunity In Mice)